- •c.919A>G genotypes AG/GG are associated with higher CPR versus genotype AA
- •c.919A>G genotypes AG/GG are associated with higher LBR versus genotype AA
- •c.2039A>G genotype GG is associated with lower CLBR versus genotype AA
Is there an association between FSHR sequence variants and reproductive outcomes following IVF in predicted normoresponders?
Multicentre prospective cohort study conducted from November 2016 to June 2019 in Vietnam, Belgium and Spain including patients aged <38 years, and undergoing IVF with a predicted normal response with fixed-dose 150 IU rFSH in an antagonist protocol. Genotyping was performed for three FSHR (c.919A>G, c.2039A>G, c.-29G>A) and one FSHB sequence variants (c.-211G>T). Clinical pregnancy rate (CPR), live birth rate (LBR) and miscarriage rate in the first embryo transfer and cumulative live birth rate (CLBR) were compared between the different genotypes.
A total of 351 patients underwent at least one embryo transfer. Genetic model analysis that adjusted for patient age, body mass index, ethnicity, type of embryo transfer, embryo stage and number of top-quality embryos transferred revealed a higher CPR for homozygous patients for the variant allele G of c.919A>G when compared to patients with genotype AA (60.3% versus 46.3%, adjusted odds ratio [ORadj] 1.96, 95% confidence interval [CI] 1.09–3.53). Also, c.919A>G genotypes AG and GG presented a higher CPR and LBR when compared with genotype AA (59.1% versus 46.3%, ORadj 1.80, 95% CI 1.08–3.00, and 51.3% versus 39.0%, ORadj 1.69, 95% CI 1.01–2.80, respectively). Cox regression models revealed a statistically significantly lower CLBR for c.2039A>G genotype GG in the codominant model (hazard ratio [HR] 0.66, 95% CI 0.43–0.99).
These results demonstrate a previously unreported association between variant c.919A>G genotype GG and higher CPR and LBR in infertile patients and reinforce a potential role for genetic background in predicting the reproductive prognosis following IVF.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Reproductive BioMedicine Online
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure.Cell. 1995; 82: 959-968https://doi.org/10.1016/0092-8674(95)90275-9
- Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis.Hum. Reprod. Update. 2018; 24: 1-16
- Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology.J. Clin. Epidemiol. 2003; 56: 297-303
- Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation.Pharmacogenet. Genomics. 2005; 15: 451-456https://doi.org/10.1097/01.fpc.0000167330.92786.5e
- The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting.Hum. Reprod. 2011; 26: 1270-1283https://doi.org/10.1093/humrep/der037
- Association of estrogen, progesterone and follicle stimulating hormone receptor polymorphisms with in vitro fertilization outcomes.Syst. Biol. Reprod. Med. 2018; 64: 260-265https://doi.org/10.1080/19396368.2018.1482030
- Frequent polymorphisms of FSH receptor do not influence antral follicle responsiveness to follicle-stimulating hormone administration as assessed by the Follicular Output RaTe (FORT).J. Assist. Reprod. Genet. 2012; 29: 657-663https://doi.org/10.1007/s10815-012-9761-7
- The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation.Clin. Endocrinol. (Oxf). 2015; 82: 577-583https://doi.org/10.1111/cen.12573
- Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET.J. Hum. Genet. 2006; 51: 665-670https://doi.org/10.1007/s10038-006-0005-5
- FSH receptor genotype is associated with pregnancy but not with ovarian response in IVF.Reprod. Biomed. Online. 2006; 13: 687-695https://doi.org/10.1016/S1472-6483(10)60660-8
- The relationship between FSH receptor polymorphism status and IVF cycle outcome: a retrospective observational study.Reprod. Biomed. Online. 2019; 39: 231-240https://doi.org/10.1016/j.rbmo.2019.05.018
- Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization.Fertil. Steril. 2013; 99 (970–8.e1)https://doi.org/10.1016/j.fertnstert.2013.01.086
- Combined assessment of polymorphisms in the LHCGR and FSHR genes predict chance of pregnancy after in vitro fertilization.Hum. Reprod. 2016; 31: 672-683https://doi.org/10.1093/humrep/dev342
- Gonadotropin receptor variants are linked to cumulative live birth rate after in vitro fertilization.J. Assist. Reprod. Genet. 2019; 36: 29-38https://doi.org/10.1007/s10815-018-1318-y
- FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs.J. Assist. Reprod. Genet. 2006; 23: 177-184https://doi.org/10.1007/s10815-005-9015-z
- Cumulative live birth rate: time for a consensus?.Hum. Reprod. 2015; 30: 2703-2707
- A common Asn680Ser polymorphism in the follicle-stimulating hormone receptor gene is not associated with ovarian response to gonadotropin stimulation in patients undergoing in vitro fertilization.Fertil. Steril. 2013; 99: 149-155https://doi.org/10.1016/j.fertnstert.2012.08.037
- Variants Ala307Ala and Ser680Ser of 307 and 680 FSHr polymorphisms negatively influence on assisted reproductive techniques outcome and determine high probability of non-pregnancy in Caucasian patients.J. Assist. Reprod. Genet. 2021; 38: 2769-2779https://doi.org/10.1007/s10815-021-02276-0
- The effect of polymorphisms in FSHR gene on late follicular phase progesterone and estradiol serum levels in predicted normoresponders.Hum. Reprod. 2022; 37: 2646-2654https://doi.org/10.1093/humrep/deac193
- Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype.J. Clin. Endocrinol. Metab. 2000; 85: 3365-3369https://doi.org/10.1210/jcem.85.9.6789
- The effect of polymorphisms in FSHR and FSHB genes on ovarian response: a prospective multicenter multinational study in Europe and Asia.Hum. Reprod. 2021; 36: 1711-1721https://doi.org/10.1093/humrep/deab068
Sinnwell, J., Schaid, D., 2021. haplo.stats: Statistical Analysis of Haplotypes with Traits and Covariates when Linkage Phase is Ambiguous. R package version 1.8.7. Available at: https://cran.r-project.org/web/packages/haplo.stats/haplo.stats.pdf
- SNPStats: a web tool for the analysis of association studies.Bioinformatics. 2006; 22: 1928-1929
- Sequence variants in FSHR and CYP19A1 genes and the ovarian response to controlled ovarian stimulation.Fertil. Steril. 2019; 112 (749–757.e2)https://doi.org/10.1016/j.fertnstert.2019.05.017
- FSH receptor (FSHR) expression in human extragonadal reproductive tissues and the developing placenta, and the impact of its deletion on pregnancy in mice.Biol. Reprod. 2014; 91: 1-15https://doi.org/10.1095/biolreprod.114.118562
- Differential regulation of human and mouse myometrial contractile activity by FSH as a function of FSH receptor density.Biol. Reprod. 2016; 95: 1-10https://doi.org/10.1095/biolreprod.116.141648
- FSH actions and pregnancy: looking beyond ovarian FSH receptors.Endocrinology. 2018; 159: 4033-4042https://doi.org/10.1210/en.2018-00497
- Deletion of fetoplacental Fshr inhibits fetal vessel angiogenesis in the mouse placenta.Mol. Cell. Endocrinol. 2018; 476: 79-83https://doi.org/10.1016/j.mce.2018.04.011
- Freeze-all versus fresh blastocyst transfer strategy during in vitro fertilisation in women with regular menstrual cycles: multicentre randomised controlled trial.BMJ. 2020; 370: m2519https://doi.org/10.1136/bmj.m2519
- Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.Hum. Reprod. 2018; 33: 1602-1618https://doi.org/10.1093/humrep/dey256
- A method for meta-analysis of molecular association studies.Stat. Med. 2005; 24: 1291-1306https://doi.org/10.1002/sim.2010
- Effects of a polymorphism in the promoter region of the follicle-stimulating hormone subunit beta (FSHB) gene on female reproductive outcomes.Genet. Test. Mol. Biomarkers. 2019; 23: 39-44https://doi.org/10.1089/gtmb.2018.0182
- IVF transfer of fresh or frozen embryos in women without polycystic ovaries.N. Engl. J. Med. 2018; 378: 137-147
Professor Nikolaos Polyzos is the Head of the Department of Reproductive Medicine of Dexeus University Hospital. With more than 140 publications in peer-reviewed journals, his research interests include reproductive endocrinology, ovarian reserve markers, poor ovarian response and the genetics of premature ovarian ageing.
This study reports a previously unreported association between homozygous recessive genotype for FSHR sequence variant c.919A>G (GG) and higher CPR and LBR in infertile patients, thereby reinforcing a potential role for genetic background in predicting the reproductive prognosis following IVF.
Published online: January 26, 2023
Accepted: January 18, 2023
Received in revised form: January 9, 2023
Received: October 4, 2022Declaration: The authors report no financial or commercial conflicts of interest.
Publication stageIn Press Journal Pre-Proof
© 2023 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.